Catalyst Wire Dossier Catalyst Wire Dossier

H001 Capsule

· Livzon Pharmaceutical Group Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H001 Capsule, covering 2025-05-09 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty [Phase 2]

See pricing